Aeglea Biotherapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $646k | 39k | 16.76 |
| 2025-06-30 | $508k | 34k | 14.97 |
| 2025-03-31 | $460k | 29k | 16.14 |
| 2024-12-31 | $731k | 31k | 23.28 |
| 2024-09-30 | $633k | 22k | 29.41 |
| 2024-06-30 | $382k | 16k | 23.51 |
| 2024-03-31 | $11k | 298 | 37.93 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft